138 related articles for article (PubMed ID: 35718584)
1. Patient Insight With Collagenase Treatment for Dupuytren: A Prospective Study.
Sanjuan-Cervero R; Gomez-Herrero D; Peña-Molina F; de la Iglesia NH; Sanjuan-Arago A; Novoa-Parra CD
J Hand Surg Am; 2023 Dec; 48(12):1274.e1-1274.e6. PubMed ID: 35718584
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study.
Gaston RG; Larsen SE; Pess GM; Coleman S; Dean B; Cohen BM; Kaufman GJ; Tursi JP; Hurst LC
J Hand Surg Am; 2015 Oct; 40(10):1963-71. PubMed ID: 26216077
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial.
Costas B; Coleman S; Kaufman G; James R; Cohen B; Gaston RG
BMC Musculoskelet Disord; 2017 Aug; 18(1):374. PubMed ID: 28854973
[TBL] [Abstract][Full Text] [Related]
4. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T
J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951
[TBL] [Abstract][Full Text] [Related]
5. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P
Orthop Traumatol Surg Res; 2018 Oct; 104(6):901-905. PubMed ID: 30253866
[TBL] [Abstract][Full Text] [Related]
7. Pain Associated With Treatment of Dupuytren Contracture With Collagenase Clostridium histolyticum.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Fikri-Benbrahim N; Franco-Ferrando N; Peimer CA
J Hand Surg Am; 2017 Feb; 42(2):e109-e114. PubMed ID: 28160905
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies.
Witthaut J; Jones G; Skrepnik N; Kushner H; Houston A; Lindau TR
J Hand Surg Am; 2013 Jan; 38(1):2-11. PubMed ID: 23218556
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Badalamente MA; Hurst LC; Benhaim P; Cohen BM
J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.
Coleman S; Gilpin D; Kaplan FT; Houston A; Kaufman GJ; Cohen BM; Jones N; Tursi JP
J Hand Surg Am; 2014 Jan; 39(1):57-64. PubMed ID: 24315486
[TBL] [Abstract][Full Text] [Related]
11. Skin laceration as a serious adverse sequela of injectable collagenase for Dupuytren contracture.
Hallock GG
Plast Reconstr Surg; 2012 Jan; 129(1):205e-206e. PubMed ID: 22186568
[No Abstract] [Full Text] [Related]
12. Anesthesia for collagenase clostridium histolyticum injection in patients with dupuytren disease: A cohort analysis.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Peimer CA
J Plast Reconstr Aesthet Surg; 2018 Aug; 71(8):1129-1137. PubMed ID: 29706551
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Skin Tears Following Collagenase Clostridium histolyticum to Treat Dupuytren Contractures.
Wei DH; Cantlon MB; Wakefield DB; Vitale MA
J Hand Surg Am; 2020 Oct; 45(10):989.e1-989.e10. PubMed ID: 32546304
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Skin Tearing in Collagenase Treatment of Dupuytren Contractures.
Zhang D; Earp BE; Blazar P
J Hand Surg Am; 2019 Dec; 44(12):1021-1025. PubMed ID: 31420243
[TBL] [Abstract][Full Text] [Related]
15. Development of Collagenase Treatment for Dupuytren Disease.
Badalamente MA; Hurst LC
Hand Clin; 2018 Aug; 34(3):345-349. PubMed ID: 30012294
[TBL] [Abstract][Full Text] [Related]
16. Limited Fasciectomy Versus Collagenase Clostridium histolyticum for Dupuytren Contracture: A Propensity Score Matched Study of Single Digit Treatment With Minimum 5 Years of Telephone Follow-Up.
Gruber JS; Zhang D; Janssen SJ; Blazar P; Jupiter JB; Earp BE
J Hand Surg Am; 2021 Oct; 46(10):888-895. PubMed ID: 34275684
[TBL] [Abstract][Full Text] [Related]
17. Long-term Effects of Skin Tearing on Outcomes After Collagenase Treatment of Dupuytren Contractures.
Zhang D; Blazar P; Benavent KA; Earp BE
Hand (N Y); 2021 Nov; 16(6):792-796. PubMed ID: 31941375
[No Abstract] [Full Text] [Related]
18. The Impact of Collagenase Clostridium histolyticum Introduction on Dupuytren Treatment Patterns in the United States.
Zhao JZ; Hadley S; Floyd E; Earp BE; Blazar PE
J Hand Surg Am; 2016 Oct; 41(10):963-968. PubMed ID: 27546441
[TBL] [Abstract][Full Text] [Related]
19. Dupuytren Cords Do Not Undergo Significant Histopathological Change After Collagenase Clostridium Histolyticum Injection.
Guo M; Yang K; Kock ND; Daley R; Dzwierzynski W; LoGiudice J; Hettinger P; Best C; Argenta A
Hand (N Y); 2023 Sep; 18(6):912-917. PubMed ID: 35081825
[No Abstract] [Full Text] [Related]
20. Toxic dermatitis secondary to treatment with collagenase clostridium histolyticum for Dupuytren´s disease.
Sanjuan-Cervero R; Poquet-Jornet JE; Carrera-Hueso FJ
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3688-91. PubMed ID: 27649672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]